FDA Center for Drug Evaluation & Research Issues Warning Letter to Baxter International
October 22, 2026
October 22, 2026
WASHINGTON, Oct. 22 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Baxter International Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Andrew Hider, President and CEO, Baxter International Inc., One Baxter Parkway, Deerfield, IL 60015, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING . . .
* * *
Recipient: Mr. Andrew Hider, President and CEO, Baxter International Inc., One Baxter Parkway, Deerfield, IL 60015, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING . . .